Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 3 Neoplasms 2 Skin Neoplasms 1 Pancreatic Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hepatitis C, Chronic 1 Hepatitis B, Chronic 1 Colonic Neoplasms 1

Interventions

Fluorouracil 34 Leucovorin 31 Oxaliplatin 25 Irinotecan 19 Capecitabine 13 Folfox protocol 12 Cetuximab 12 Chemotherapy, Adjuvant 11 Bevacizumab 9 Neoadjuvant Therapy 8 Drug Therapy 8 XELOX 7 Laparoscopy 7 Endoscopic Mucosal Resection 5 Colonoscopy 5 Surgical Procedures, Operative 4 Gemcitabine 4 Tegafur 3 Radiotherapy 3 Propofol 3 Preoperative Exercise 3 Panitumumab 3 Fentanyl 3 Curcumin 3 Colectomy 3 Aspirin 3 raltitrexed 2 Surveys and Questionnaires 2 Sodium Chloride 2 Simvastatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Colonic Neoplasms × peginterferon alfa-2a × Clear all

NCT04798612 2023-08-18

IPOS

Zealand University Hospital

Phase 2 Unknown

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡